The assessment of future RSV immunizations: How to protect all infants?

Louis Bont; Catherine Weil Olivier; Egbert Herting; Susanna Esposito; Jose Antonio Navarro Alonso; Federico Lega; Silke Mader; Ichiro Morioka; Kunling Shen; George A. Syrogiannopoulos; Saul N. Faust; Elena Bozzola

doi:10.3389/fped.2022.981741

The assessment of future RSV immunizations: How to protect all infants?

Louis Bont, Catherine Weil Olivier, Egbert Herting, Susanna Esposito, Jose Antonio Navarro Alonso, Federico Lega, Silke Mader, Ichiro Morioka, Kunling Shen, George A. Syrogiannopoulos, Saul N. Faust, Elena Bozzola^*

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Kinder- und Jugendmedizin

13 Zitate (Scopus)

Originalsprache	Englisch
Aufsatznummer	981741
Zeitschrift	Frontiers in Pediatrics
Jahrgang	10
ISSN	2296-2360
DOIs	https://doi.org/10.3389/fped.2022.981741
Publikationsstatus	Veröffentlicht - 09.08.2022

Fördermittel

Sanofi and AstraZeneca facilitated and financially supported the RSV Experts Group Event, remuneration to some of the experts was agreed for the time spent for the meeting but the authors were not paid for writing the publication. Funding for the publication fees was provided by Sanofi and AstraZeneca. Hyderus CYF—was paid by Sanofi and AstraZeneca for the expert meeting organization, medical writing, and editorial support.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Dokumente

10.3389/fped.2022.981741

Weitere Links

Link to publication in Scopus

Zitieren

@article{7095850c3059459abf04c0c41e0409cb,

title = "The assessment of future RSV immunizations: How to protect all infants?",

author = "Louis Bont and \{Weil Olivier\}, Catherine and Egbert Herting and Susanna Esposito and \{Navarro Alonso\}, \{Jose Antonio\} and Federico Lega and Silke Mader and Ichiro Morioka and Kunling Shen and Syrogiannopoulos, \{George A.\} and Faust, \{Saul N.\} and Elena Bozzola",

note = "Funding Information: Sanofi and AstraZeneca facilitated and financially supported the RSV Experts Group Event, remuneration to some of the experts was agreed for the time spent for the meeting but the authors were not paid for writing the publication. Funding for the publication fees was provided by Sanofi and AstraZeneca. Hyderus CYF—was paid by Sanofi and AstraZeneca for the expert meeting organization, medical writing, and editorial support. ",

year = "2022",

month = aug,

day = "9",

doi = "10.3389/fped.2022.981741",

language = "English",

volume = "10",

journal = "Frontiers in Pediatrics",

issn = "2296-2360",

}

TY - JOUR

T1 - The assessment of future RSV immunizations

T2 - How to protect all infants?

AU - Bont, Louis

AU - Weil Olivier, Catherine

AU - Herting, Egbert

AU - Esposito, Susanna

AU - Navarro Alonso, Jose Antonio

AU - Lega, Federico

AU - Mader, Silke

AU - Morioka, Ichiro

AU - Shen, Kunling

AU - Syrogiannopoulos, George A.

AU - Faust, Saul N.

AU - Bozzola, Elena

N1 - Funding Information: Sanofi and AstraZeneca facilitated and financially supported the RSV Experts Group Event, remuneration to some of the experts was agreed for the time spent for the meeting but the authors were not paid for writing the publication. Funding for the publication fees was provided by Sanofi and AstraZeneca. Hyderus CYF—was paid by Sanofi and AstraZeneca for the expert meeting organization, medical writing, and editorial support.

PY - 2022/8/9

Y1 - 2022/8/9

UR - https://www.scopus.com/pages/publications/85136906320

U2 - 10.3389/fped.2022.981741

DO - 10.3389/fped.2022.981741

M3 - Journal articles

AN - SCOPUS:85136906320

SN - 2296-2360

VL - 10

JO - Frontiers in Pediatrics

JF - Frontiers in Pediatrics

M1 - 981741

ER -